Xiyang Tang

Qi-Li-Qiang-Xin Alleviates Isoproterenol-Induced Myocardial Injury by Inhibiting Excessive Autophagy via Activating AKT/mTOR Pathway

Cailian Fan, Xiyang Tang, Meng‐nan Ye et al. · Frontiers in Pharmacology · 2019 · 60 citations · Full text

Medicine, Cardiology, Pharmacology +16

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis

Xiyang Tang, Yanlu Xiong, Yabo Zhao et al. · Frontiers in Immunology · 2022 · 54 citations · Full text

Medicine, Immunology, Oncology +17

Systematic screening and characterization of Qi-Li-Qiang-Xin capsule-related xenobiotics in rats by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry

Weijing Yun, Zhihong Yao, Cailian Fan et al. · Journal of Chromatography B · 2018 · 39 citations

Pharmacy, Pharmacology, Toxicology +16

A combination of representative compounds, metabolism platform and diagnostic extraction strategy for characterization of metabolites of Shuang-Huang-Lian oral liquid in vivo by ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry

Fengxiang Zhang, Zhi-neng Xie, Xiyang Tang et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 34 citations

Life Sciences, Biochemistry, Pharmacology +17

Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR

Fangfang Wang, Sora Jin, Franklin Mayca Pozo et al. · Acta Pharmaceutica Sinica B · 2021 · 32 citations · Full text

Medicine, Cancer Biology, Oncology +16